Cipla has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Darifenacin extended-release tablets. Darifenacin extended-release tablets are AB-rated generic equivalents of […]
Strides Shasun has received USFDA approval for Ranitidine tablets. The drug Ranitidine is used to treat ulcers of the stomach and intestines and to prevent […]
Claris Lifesciences has received USFDA approval for generic Flumazenil injection used for reversal of the sedative effects of benzodiazepines in the United States. The company […]
Jubilant Life Sciences has received USFDA approval for Telmisartan Tablets, used for the treatment of hypertension, in the U.S. market. The final approval is for […]
Cipla has received final USFDA approval to market generic Bupropion Hydrochloride extended release tablets used for treatment of major depressive disorder through its subsidiary InvaGen […]
Dr Reddy’s Laboratories has launched Nitroglycerin sublingual tablets, a therapeutic equivalent generic version of Nitrostat (Nitroglycerin) sublingual tablets in the US. The drug which is […]
Glenmark Pharmaceuticals has received final approval from USFDA for its generic version of AstraZeneca’s Xylocaine ointment. The approval is for Lidocaine Ointment USP, 5 per […]
Ortin Laboratories is planning to set up a drug intermediates unit at Malkapur village, Choutuppal mandal in Nalgonda district of Telangana. The project cost is […]
Copyright © 2024 | WordPress Theme by MH Themes